These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21494016)

  • 41. Public attitudes towards preventive genomics and personal interest in genetic testing to prevent disease: a survey study.
    Vermeulen E; Henneman L; van El CG; Cornel MC
    Eur J Public Health; 2014 Oct; 24(5):768-75. PubMed ID: 24068545
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-invasive prenatal genetic testing: a study of public attitudes.
    Kelly SE; Farrimond HR
    Public Health Genomics; 2012; 15(2):73-81. PubMed ID: 22094262
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Australians' knowledge and perceptions of direct-to-consumer personal genome testing.
    Savard J; Mooney-Somers J; Newson AJ; Kerridge I
    Intern Med J; 2014 Jan; 44(1):27-31. PubMed ID: 24450520
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Attitudes and misconceptions about predictive genetic testing for cancer risk.
    Rose AL; Peters N; Shea JA; Armstrong K
    Community Genet; 2005; 8(3):145-51. PubMed ID: 16113531
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lay Attitudes toward Genetic Testing for Susceptibility to Inherited Diseases.
    Shaw JS; Bassi KL
    J Health Psychol; 2001 Jul; 6(4):405-23. PubMed ID: 22049389
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictors of interest in direct-to-consumer genetic testing.
    Sweeny K; Legg AM
    Psychol Health; 2011 Oct; 26(10):1259-72. PubMed ID: 21500101
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The general public's understanding and perception of direct-to-consumer genetic test results.
    Leighton JW; Valverde K; Bernhardt BA
    Public Health Genomics; 2012; 15(1):11-21. PubMed ID: 21720148
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Public interest in genetic testing for susceptibility to heart disease and cancer: a population-based survey in the UK.
    Sanderson SC; Wardle J; Jarvis MJ; Humphries SE
    Prev Med; 2004 Sep; 39(3):458-64. PubMed ID: 15313084
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Attitudes toward genetic testing in a german population.
    Balck F; Berth H; Meyer W
    Genet Test Mol Biomarkers; 2009 Dec; 13(6):743-50. PubMed ID: 19810825
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Public attitudes in Australia towards the claim that addiction is a (brain) disease.
    Meurk C; Partridge B; Carter A; Hall W; Morphett K; Lucke J
    Drug Alcohol Rev; 2014 May; 33(3):272-9. PubMed ID: 24612302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic Testing Awareness and Attitudes among Latinos: Exploring Shared Perceptions and Gender-Based Differences.
    Hamilton JG; Shuk E; Arniella G; González CJ; Gold GS; Gany F; Robson ME; Hay JL
    Public Health Genomics; 2016; 19(1):34-46. PubMed ID: 26555145
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic testing for late-onset diseases: effect of disease controllability, test predictivity, and gender on the decision to take the test.
    Barnoy S
    Genet Test; 2007; 11(2):187-92. PubMed ID: 17627392
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Health Care Utilization by Canadian Women.
    Kazanjian A; Morettin D; Cho R
    BMC Womens Health; 2004 Aug; 4 Suppl 1(Suppl 1):S33. PubMed ID: 15345096
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Public attitudes toward genetic testing: perceived benefits and objections.
    Henneman L; Timmermans DR; Van Der Wal G
    Genet Test; 2006; 10(2):139-45. PubMed ID: 16792518
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vulnerability and social justice as factors in emergent U.S. nanotechnology risk perceptions.
    Conti J; Satterfield T; Harthorn BH
    Risk Anal; 2011 Nov; 31(11):1734-48. PubMed ID: 21453374
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Public attitudes about genetic testing for Alzheimer's disease.
    Neumann PJ; Hammitt JK; Mueller C; Fillit HM; Hill J; Tetteh NA; Kosik KS
    Health Aff (Millwood); 2001; 20(5):252-64. PubMed ID: 11558711
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An epidemiologic-based survey of public attitudes towards predictive genetic testing in Russia.
    Makeeva OA; Markova VV; Roses AD; Puzyrev VP
    Per Med; 2010 May; 7(3):291-300. PubMed ID: 29776224
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Public attitudes and beliefs about genetics.
    Condit CM
    Annu Rev Genomics Hum Genet; 2010; 11():339-59. PubMed ID: 20690816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genomics in primary care practice.
    Teng K; Acheson LS
    Prim Care; 2014 Jun; 41(2):421-35. PubMed ID: 24830615
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic epidemiology and public health: hope, hype, and future prospects.
    Davey Smith G; Ebrahim S; Lewis S; Hansell AL; Palmer LJ; Burton PR
    Lancet; 2005 Oct 22-28; 366(9495):1484-98. PubMed ID: 16243094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.